SOLENO THERAPEUTICS INC (SLNO) Stock Analyst Ratings
NASDAQ:SLNO - Nasdaq - US8342033094 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 86% to SLNO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 75.74. This target is 64.18% above the current price.
SLNO was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SLNO.
In the previous month the buy percentage consensus was at a similar level.
SLNO was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-02 | Baird | Reiterate | Outperform -> Outperform |
| 2024-12-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-01 | Stifel | Maintains | Buy -> Buy |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-09-03 | HC Wainwright & Co. | Initiate | Buy |
| 2024-08-12 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-07-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-10 | Baird | Initiate | Outperform |
| 2024-02-05 | Piper Sandler | Initiate | Overweight |
| 2024-01-23 | Stifel | Initiate | Buy |
| 2024-01-02 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-09-26 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-09-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-11 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-05-25 | Oppenheimer | Reiterate | Outperform |
| 2023-03-24 | Oppenheimer | Reiterate | Outperform |